Chronic myelogenous leukemia evolving after treatment of multiple myeloma

Blood. 2016 Jul 7;128(1):146. doi: 10.1182/blood-2016-03-706945.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Bone Marrow / drug effects
  • Bone Marrow / pathology
  • Bortezomib / therapeutic use
  • Dexamethasone / therapeutic use
  • Female
  • Humans
  • Imatinib Mesylate / therapeutic use
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / etiology*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology
  • Middle Aged
  • Multiple Myeloma / complications*
  • Multiple Myeloma / drug therapy*
  • Multiple Myeloma / pathology

Substances

  • Antineoplastic Agents
  • Bortezomib
  • Dexamethasone
  • Imatinib Mesylate